Firefly Neuroscience, Inc. (AIFF) Research

Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.

Market snapshot

Symbol
AIFF
Price
$1.37
Day change
-4.86%
Market cap
$21.3M
P/E ratio
-2.48x
52-week range
0.62-3.77
Sector
Technology
Industry
Software - Application
Next earnings
in 11 days

Peer companies

  • Sphere 3D Corp. (ANY)
  • Arbe Robotics Ltd. (ARBE)
  • ConnectM Technology Solutions, Inc. (CNTM)
  • CXApp Inc. (CXAI)
  • MIND C.T.I. Ltd (MNDO)
  • NetClass Technology Inc (NTCL)
  • NextPlat Corp (NXPL)
  • Real Messenger Corporation (RMSG)

Recent insider activity

  • Lipschitz Gregory — trade (0 shares) on 2024-08-12
  • DeCaprio David — A-Award (44872 shares) on 2026-03-10
  • Lipschitz Gregory — A-Award (65988 shares) on 2026-03-10
  • Menawat Arun Swarup — A-Award (73892 shares) on 2025-10-28
  • POSNER BRIAN M — A-Award (49262 shares) on 2025-10-28

Open Firefly Neuroscience, Inc. (AIFF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.